Geneos Wealth Management’s Sylvamo SLVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.38K Hold
63
﹤0.01% 2305
2026
Q1
$2.66K Buy
63
+11
+21% +$515 ﹤0.01% 2273
2025
Q4
$2.5K Hold
52
﹤0.01% 2285
2025
Q3
$2.3K Sell
52
-239
-82% -$11.1K ﹤0.01% 2296
2025
Q2
$14.6K Sell
291
-7
-2% -$394 ﹤0.01% 2167
2025
Q1
$20K Buy
298
+68
+30% +$4.96K ﹤0.01% 1949
2024
Q4
$18.2K Hold
230
﹤0.01% 1769
2024
Q3
$19.7K Buy
230
+149
+184% +$11.1K ﹤0.01% 1560
2024
Q2
$5.56K Hold
81
﹤0.01% 1696
2024
Q1
$5K Hold
81
﹤0.01% 1708
2023
Q4
$3.98K Hold
81
﹤0.01% 1778
2023
Q3
$3.56K Sell
81
-31
-28% -$1.33K ﹤0.01% 1832
2023
Q2
$4.53K Hold
112
﹤0.01% 1764
2023
Q1
$5.18K Hold
112
﹤0.01% 1718
2022
Q4
$5.44K Sell
112
-54
-33% -$2.59K ﹤0.01% 1688
2022
Q3
$5K Sell
166
-56
-25% -$2.13K ﹤0.01% 1700
2022
Q2
$7K Sell
222
-3
-1% -$126 ﹤0.01% 2099
2022
Q1
$7K Buy
+225
New +$7.47K ﹤0.01% 2246

Other funds holding SLVM

Geneos Wealth Management's SLVM Position: Q2 2026 in Review

Geneos Wealth Management held its Sylvamo (SLVM) position steady in Q2 2026 at 63 shares worth $2.38K. The position accounts for ﹤0.01% of the portfolio, ranked #2305.

Geneos Wealth Management first reported a position in SLVM in Q1 2022 and has held it in 18 quarters since. The position peaked at $20K in Q1 2025. 333 funds tracked by Wall St. Rank hold SLVM as of Q2 2026.

  • Geneos Wealth Management held 63 shares of Sylvamo worth $2.38K as of Q2 2026.
  • Geneos Wealth Management left its Sylvamo share count unchanged in Q2 2026.
  • Sylvamo made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #2305 holding.
  • Geneos Wealth Management first reported a position in Sylvamo in Q1 2022 and has held it in 18 quarters since.
  • Geneos Wealth Management's Sylvamo position peaked at $20K in Q1 2025.
  • 333 funds tracked by Wall St. Rank held Sylvamo as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.